RegImmune, JDRF and Pfizer team up to develop antigen-specific immunotherapy for type 1 diabetes April 16, 2015
SBIR grant supports Xeris' development of stable non-aqueous glucagon for congenital hyperinsulinism April 15, 2015
Neothetics initiates phase III trials of LIPO-202 for reduction of subcutaneous abdominal fat April 14, 2015
RSS